SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma - Docwire News Doc Wire News, 17 Jun 2021 This article was originally published here Biomark Res. 2021 Jun 16;9(1):48. doi: 10.1186/s40364-021-00296-7.